Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report.
A 47-yr-old man with hepatitis B virus associated liver cirrhosis was admitted to our hospital with diarrhea and generalized edema and diagnosed as protein-losing enteropathy due to intestinal lymphangiectasia by intestinal biopsy and 99m Tc albumin scan. During hospitalization, he received subcutaneous octreotide therapy. After 2 weeks of octreotide therapy, follow-up albumin scan showed no albumin leakage, and the serum albumin level was sustained. We speculate that liver cirrhosis can be a cause of intestinal lymphangiectasia and administration of octreotide should be considered for patients with intestinal lymphangiectasia whose clinical and bio-chemical abnormalities do not respond to a low-fat diet.
Lee
Hang Lak
HL
Department of Internal Medicine, Hanyang University Kuri Hospital, Guri, Korea.
Han
Dong Soo
DS
Kim
Jin Bae
JB
Jeon
Yong Chul
YC
Sohn
Joo Hyun
JH
Hahm
Joon Soo
JS
D000293:Adolescent; D000328:Adult; D004386:Duodenum / Q000473:pathology; D005260:Female; D006509:Hepatitis B / Q000150:complications; D006515:Hepatitis B virus / Q000378:metabolism; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy* / Q000821:virology; D007583:Jejunum / Q000473:pathology; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000821:virology; D008201:Lymphangiectasis, Intestinal / Q000188:drug therapy* / Q000821:virology; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000494:pharmacology*; D011504:Protein-Losing Enteropathies / Q000188:drug therapy*
D015282:Octreotide